Rivaara Labs

Home
India
Mumbai
Rivaara Labs

Call Directions Website Contact the practice

Rivaara Labs is an exclusive lab chain for molecular diagnostics in India.

13/09/2026

Spot Sepsis. Stop Sepsis. Save Lives. 💙

Sepsis can escalate rapidly. Early detection can help clinicians make faster, more informed treatment decisions.

At RIVAARA Labs, we believe in the power of advanced molecular diagnostics to support rapid and reliable detection of sepsis-associated pathogens and resistance markers.

This World Sepsis Day, let’s act early. Because every moment counts.

17/08/2026

A productive and insightful participation at NOVA IX PACS 2026, New Delhi.

RIVAARA Labs was proud to engage with leading pulmonologists, critical care specialists and healthcare professionals, showcasing the role of molecular diagnostics in faster pathogen detection, antimicrobial resistance identification and informed clinical decision-making.

Our conversations at the conference reinforced an important message: when every hour matters, timely and accurate diagnosis can make a difference.

We thank the PACS India team, distinguished faculty, healthcare professionals and everyone who visited the RIVAARA booth and engaged with our team.

RIVAARA Labs — Advancing Molecular Diagnostics for Better Clinical Decisions.

CriticalCare Sepsis AMR AntimicrobialResistance InfectiousDiseases Diagnostics

15/08/2026

🇮🇳 Celebrating 80 Years of Freedom, Unity & Progress! 🇮🇳

This Independence Day, RIVAARA LABS celebrates the spirit of a nation that continues to move forward with resilience, innovation, and purpose.

As we contribute to a healthier India through molecular diagnostics and better healthcare solutions, we remain committed to building a future where every advancement brings us closer to better health outcomes.

Proud to be Indian. Committed to a healthier future.

🇮🇳 Happy Independence Day! 🇮🇳

HealthyIndia ProudIndian Diagnostics IndiaAt80

24/06/2026

Not every flu is just the flu. Test, don’t guess.

Influenza-like illness can present with overlapping symptoms, while the underlying pathogen may vary. Timely, accurate identification can support more informed clinical decisions and better patient management.
Rivaara Labs offers RT-PCR solutions for flu pathogens through a range of flu testing panels:

One Test. Multiple Answers. Better Clinical Decisions.

07/05/2026

Empirical antibiotics remain crucial in critical infections—but when patients fail to improve, identifying the exact pathogen quickly becomes equally important.
Dr. Kusum Sikariya shares a real-world meningitis case where rapid PCR-based testing helped detect the causative pathogen and supported a shift toward more targeted treatment.
This case highlights the growing importance of molecular diagnostics in supporting faster clinical decision-making in ICU and neuro-critical care settings.

11/04/2026

Sepsis continues to be a race against time—where early, informed decisions can significantly impact patient outcomes.

In this testimonial, Dr. Nikhil Varge (Intensivist Faculty) presents a real-world sepsis case, detailing the patient’s clinical condition and the challenges faced in early diagnosis and management. He highlights how the Rivaaras SeptiQuik Panel enabled rapid pathogen identification along with antimicrobial resistance (AMR) insights, facilitating timely, targeted therapy.

This case underscores the growing importance of rapid molecular diagnostics in critical care—especially in the face of rising AMR.

Watch the full video to gain practical clinical insights.

10/04/2026

Every Hour Counts in Pediatric Sepsis ⏳
In India, sepsis continues to be a silent emergency—especially among our youngest patients.
🔬 Over 1 lakh cases reported annually
👶 Nearly 40% affect children under 5
⚠️ Newborns remain at the highest risk
💔 Severe cases can see mortality rates as high as 30–35%
With rising antimicrobial resistance, first-line treatments are becoming less effective—making early, accurate diagnosis more critical than ever.
At Rivaara Labs, we believe timely molecular diagnostics can help clinicians move from uncertainty to precision—saving lives when it matters most.
👉 Because in pediatric sepsis, survival should depend on certainty, not chance.

17/03/2026

When Every Hour Matters in Sepsis ⏱️

In a real-world case, Dr. Jithesh Gangadharan, EMS hospital, Kerala, highlights how rapid identification of the causative pathogen and AMR gene using Rivaara Labs’ SeptiQuik Panel supported timely, targeted clinical decisions in a critical sepsis patient.
With rising antimicrobial resistance (AMR) complicating outcomes, early molecular insights are no longer optional—they are essential.

SPOT SEPSIS. STOP SEPSIS.

16/02/2026

Superbugs are rising, and antibiotics are losing their effectiveness.

ICMR insights highlight a growing burden of drug-resistant infections, especially in critical care. Early and precise diagnosis is now essential to guide targeted therapy and improve patient outcomes.

At Rivaara Labs, we are committed to enabling clinicians with advanced molecular diagnostics to support faster, evidence-based treatment decisions.

Because today’s infection should never become tomorrow’s untreatable disease.

25/01/2026

This Republic Day, we celebrate the spirit of India and our shared responsibility to build a healthier nation.

At Rivaara Labs, we remain committed to advancing molecular diagnostics that support timely, precise, and responsible clinical care.

🇮🇳 Happy Republic Day!

Address

17th Floor, Hoechst House, Nariman Point
Mumbai
400021

Telephone

+919301000083

Website

https://rivaaralabs.com/

Alerts

Be the first to know and let us send you an email when Rivaara Labs posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Rivaara Labs: